CARM

Carisma Therapeutics
CARM

Delisted

CARM was delisted on the 10th of October, 2025.

46 hedge funds and large institutions have $78.2M invested in Carisma Therapeutics in 2018 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more first-time investments, than exits

New positions opened: | Existing positions closed:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more funds holding

Funds holding:

40% more call options, than puts

Call options by funds: $1.23M | Put options by funds: $878K

1.4% more ownership

Funds ownership: 1.22%2.62% (+1.4%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
46
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.23M
Puts
$878K
Net Calls
Net Calls Change

Top Buyers

1 +$14.7M
2 +$13.3M
3 +$7.25M
4
KCM
Kingdon Capital Management
New York
+$6.32M
5
BBA
Baker Bros. Advisors
New York
+$5.12M

Top Sellers

1 -$1.67M
2 -$1.29M
3 -$258K
4
Squarepoint
Squarepoint
New York
-$40K
5
Simplex Trading
Simplex Trading
Illinois
-$36K
Name Holding Trade Value Shares
Change
Change in
Stake
26
$63K
27
$59K
28
$55K
29
$39K
30
$37K
31
$37K
32
$35K
33
$22K
34
$22K
35
$18K
36
$8K
37
$5K
38
$4K
39
$3K
40
$2K
41
$2K
42
$1.95K
43
$1K
44
$1K
45
$1K
46
47
48
49
50